Patent · US Active

HLA-A2 tumor associated antigen peptides and compositions

US8007810B2 · kind B2 · utility

11Cited by
0References
11Claims
0Family size

Assignee

Inventors

Key dates

Filing dateFeb 23, 2010
Grant dateAug 30, 2011
Priority date—
Expiry dateFeb 23, 2030

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K2239/31
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

A peptide or composition comprising at least one HLA-A2 epitope or analog from CEA, HER2/neu, MAGE2, MAGE3, or p53.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.